Conference Coverage
Conference Coverage
Biologic efficacy differs in psoriatic arthritis by lymphocyte phenotype
News
Risankizumab impresses in phase 2 psoriatic arthritis trial
Conference Coverage
EULAR scientific program highlights spectrum of translational research
Conference Coverage
Ixekizumab improves psoriatic arthritis patient-reported outcomes
Ixekizumab improved patient-reported physical function, quality of life, itch score, and work productivity in the SPIRIT-P2 trial.
Conference Coverage
Psoriatic arthritis patients’ cardiovascular risks aren’t spurring increased management
Patients with PsA have a higher risk for cardiovascular morbidity but are managed with the same intensity as the general population.
Conference Coverage
CBC values linked to CVD risk in psoriasis
ORLANDO – Red cell distribution width – a measure of the range of red blood cell volumes in a given sample – and mean platelet volume are...
Conference Coverage
VIDEO: Second wave of psoriatic arthritis therapies
SANDESTIN, FLA. – A new surge of interest in psoriatic arthritis research is underway, which signals an array of new options to target various...
Conference Coverage
Novel x-ray score distinguishes psoriatic arthritis from osteoarthritis of the hand
LIVERPOOL, ENGLAND – The scoring system correctly allocated 100% of images.
Conference Coverage
Methotrexate-induced pulmonary fibrosis risk examined in 10-year study
LIVERPOOL, ENGLAND – There is no evidence that pulmonary fibrosis is a complication of long-term methotrexate use and treatment should continue...
Conference Coverage
Family history of psoriasis and PsA predicts disease phenotype
Some rheumatologic family history may predict disease phenotype for psoriasis and psoriatic arthritis.